- Home
- INVA vs MFIC Comparison
INVA vs MFIC Comparison
Compare INVA & MFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- MFIC
- Stock Information
- Founded
- INVA 1996
- MFIC 2004
- Country
- INVA United States
- MFIC United States
- Employees
- INVA N/A
- MFIC N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- MFIC Finance/Investors Services
- Sector
- INVA Health Care
- MFIC Finance
- Exchange
- INVA Nasdaq
- MFIC Nasdaq
- Market Cap
- INVA 1.4B
- MFIC 1.1B
- IPO Year
- INVA 2004
- MFIC 2004
- Fundamental
- Price
- INVA $19.40
- MFIC $12.67
- Analyst Decision
- INVA Buy
- MFIC Buy
- Analyst Count
- INVA 1
- MFIC 5
- Target Price
- INVA $55.00
- MFIC $13.60
- AVG Volume (30 Days)
- INVA 1.0M
- MFIC 457.0K
- Earning Date
- INVA 07-30-2025
- MFIC 08-06-2025
- Dividend Yield
- INVA N/A
- MFIC 12.01%
- EPS Growth
- INVA N/A
- MFIC N/A
- EPS
- INVA N/A
- MFIC 1.22
- Revenue
- INVA $369,844,000.00
- MFIC $312,149,000.00
- Revenue This Year
- INVA $3.75
- MFIC $9.71
- Revenue Next Year
- INVA $12.62
- MFIC $0.21
- P/E Ratio
- INVA N/A
- MFIC $10.38
- Revenue Growth
- INVA 18.70
- MFIC 12.66
- 52 Week Low
- INVA $16.19
- MFIC $10.18
- 52 Week High
- INVA $22.00
- MFIC $15.70
- Technical
- Relative Strength Index (RSI)
- INVA 34.88
- MFIC 54.87
- Support Level
- INVA $19.68
- MFIC $12.44
- Resistance Level
- INVA $21.97
- MFIC $12.67
- Average True Range (ATR)
- INVA 0.60
- MFIC 0.20
- MACD
- INVA -0.29
- MFIC 0.01
- Stochastic Oscillator
- INVA 1.33
- MFIC 98.39
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About MFIC MidCap Financial Investment Corporation
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.